Spotlight on Value Calculators for Specialty Drugs: "Is There a Mathematical Resolution to the Cost-Versus-Value Debate?”

February 2016

For Specialty Physicians:

VitalSource™ GPO
Multi-Specialty Solutions
Oncology Solutions
Urology Solutions

For Specialty Manufacturers:

Business Solutions
Logistical Solutions
Patient Solutions

Bruce Feinberg, DO

Vice President
Chief Medical Officer 
Cardinal Health Specialty Solutions

Lincy S. Lal, PharMD, PHD

Dr. Lal is director of HEOR, Clinical Specialty, Specialty Solutions, Cardinal Health, and lecturer, University of Texas School of Public Health in Houston.

J. Michael Swint, PhD

Dr. Swint is professor of health economics, Department of Management, Policy and Community Health, University of Texas School of Public Health in Houston, and professor of health economics, Center for Clinical Research and Evidenced-Based Medicine, University of Texas Medical School at Houston.

As focus on the rising cost of cancer specialty drugs is transitioning to a debate over value-based care, the topic of using ‘Value Calculator’ methodologies to measure and compare the overall value of cancer therapies is becoming the subject of frequent and heated discussion.

This is the topic of an article by Dr. Bruce Feinberg and Dr. Lincy S. Lal of Cardinal Health Specialty Solutions, and Dr. J. Michael Swint of the University of Texas in Houston, recently published in the American Journal of Managed Care’s Evidence-Based Oncology.

In their article, "Is There a Mathematical Resolution to the Cost-Versus-Value Debate?”, the authors take a detailed look at three value-based care models being developed by influential professional society and provider organizations. The team describes three models including the ASCO Value Framework, DrugAbacus from Memorial Sloan Kettering Cancer Center, and Evidence Blocks from NCCN, and how they determine value as a combination of factors that can include; safety, efficacy, efficiency, consistency of evidence, and equity.

Real-world Insights

Make informed decisions with evidence-based HEOR studies in oncology, rheumatology and other specialty therapeutic areas.

Members Login

Sign in to the members-only section of VitalSource™ GPO

Your portal to valuable resources designed to help maximize profitability and optimize efficiency.

Become a member today

VitalSource™ GPO is a consultative partner who delivers meaningful solutions to make your business more successful.

Join now